The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.
PanCAN has invested tens of millions of dollars in research grants to advance science and medicine and improve outcomes for patients. Learn more (https://www.pancan.org/research/) .
January 14, 2021
Article
The other half of the Siegfried and Roy duo famous for their Vegas act died on Thursday from terminal pancreatic cancer.
December 02, 2020
Video
The research process for pancreatic cancer is long and difficult, but a new method of clinical trials is looking to adapt to a growing field and find ways to speed up research without losing efficiency.
October 14, 2020
Article
Adaptive Clinical Trial Design Is More Cost Effective, Patient-Centric and Allows for Faster Learning Than Standard Trials
November 28, 2018
Article
Adaptive clinical trials are poised to deliver hope to patients with pancreatic cancer.
Areas Patients with CLL Can Focus On to Maintain Their Health Beyond Treatment
Enhertu Receives FDA Approval for Gastroesophageal, Gastric Cancer Subset
Blue Note Therapeutics Partners With Several Nonprofits, Advocacy Groups to Deliver Digital Cancer-Related Mental Health Care Amid COVID-19 Pandemic
Friday Frontline: An Oncologist Forgives $650,00 in Medical Debt From His Patients, ‘Saved By The Bell’ Star Dustin Diamond Diagnosed with Stage 4 Cancer, And More